과제정보
The authors are grateful for the support of the tissue specimens and the image data from the cooperative units (Sichuan Provincial people's Hospital, China, Zigong fourth people's Hospital, Sichuan, China and Chinese PLA General Hospital [301 Hospital]).
참고문헌
- Lau HD, Chan E, Fan AC, Kunder CA, Williamson SR, Zhou M, et al. A clinicopathologic and molecular analysis of fumarate hydratase-deficient renal cell carcinoma in 32 patients. Am J Surg Pathol 2020;44:98-110 https://doi.org/10.1097/PAS.0000000000001372
- Trpkov K, Hes O, Agaimy A, Bonert M, Martinek P, Magi-Galluzzi C, et al. Fumarate hydratase-deficient renal cell carcinoma is strongly correlated with fumarate hydratase mutation and hereditary leiomyomatosis and renal cell carcinoma syndrome. Am J Surg Pathol 2016;40:865-875 https://doi.org/10.1097/PAS.0000000000000617
- Smith SC, Trpkov K, Chen YB, Mehra R, Sirohi D, Ohe C, et al. Tubulocystic carcinoma of the kidney with poorly differentiated foci: a frequent morphologic pattern of fumarate hydratase-deficient renal cell carcinoma. Am J Surg Pathol 2016;40:1457-1472 https://doi.org/10.1097/PAS.0000000000000719
- Pan X, Zhang M, Yao J, Zeng H, Nie L, Gong J, et al. Fumaratehydratase-deficient renal cell carcinoma: a clinicopathological and molecular study of 13 cases. J Clin Pathol 2019;72:748-754 https://doi.org/10.1136/jclinpath-2019-205924
- Sun G, Zhang X, Liang J, Pan X, Zhu S, Liu Z, et al. Integrated molecular characterization of fumarate hydratase-deficient renal cell carcinoma. Clin Cancer Res 2021;27:1734-1743 https://doi.org/10.1158/1078-0432.CCR-20-3788
- Gupta S, Erickson LA. Fumarate hydratase-deficient renal cell carcinoma. Mayo Clin Proc 2020;95:619-621 https://doi.org/10.1016/j.mayocp.2020.01.026
- Patel VM, Handler MZ, Schwartz RA, Lambert WC. Hereditary leiomyomatosis and renal cell cancer syndrome: an update and review. J Am Acad Dermatol 2017;77:149-158 https://doi.org/10.1016/j.jaad.2017.01.023
- Skala SL, Dhanasekaran SM, Mehra R. Hereditary leiomyomatosis and renal cell carcinoma syndrome (HLRCC): a contemporary review and practical discussion of the differential diagnosis for HLRCC-associated renal cell carcinoma. Arch Pathol Lab Med 2018;142:1202-1215 https://doi.org/10.5858/arpa.2018-0216-RA
- Grubb RL 3rd, Franks ME, Toro J, Middelton L, Choyke L, Fowler S, et al. Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer. J Urol 2007;177:2074-2079 https://doi.org/10.1016/j.juro.2007.01.155
- Refae MA, Wong N, Patenaude F, Begin LR, Foulkes WD. Hereditary leiomyomatosis and renal cell cancer: an unusual and aggressive form of hereditary renal carcinoma. Nat Clin Pract Oncol 2007;4:256-261 https://doi.org/10.1038/ncponc0773
- Freifeld Y, Ananthakrishnan L, Margulis V. Imaging for screening and surveillance of patients with hereditary forms of renal cell carcinoma. Curr Urol Rep 2018;19:82
- Paschall AK, Nikpanah M, Farhadi F, Jones EC, Wakim PG, Dwyer AJ, et al. Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome: spectrum of imaging findings. Clin Imaging 2020;68:14-19 https://doi.org/10.1016/j.clinimag.2020.06.010
- Ooi A. Advances in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) research. Semin Cancer Biol 2020;61:158-166 https://doi.org/10.1016/j.semcancer.2019.10.016
- Nikolovski I, Carlo MI, Chen YB, Vargas HA. Imaging features of fumarate hydratase-deficient renal cell carcinomas: a retrospective study. Cancer Imaging 2021;21:24
- Gardie B, Remenieras A, Kattygnarath D, Bombled J, Lefevre S, Perrier-Trudova V, et al. Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma. J Med Genet 2011;48:226-234 https://doi.org/10.1136/jmg.2010.085068
- Sudarshan S, Pinto PA, Neckers L, Linehan WM. Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancer. Nat Clin Pract Urol 2007;4:104-110 https://doi.org/10.1038/ncpuro0711
- Adam J, Hatipoglu E, O'Flaherty L, Ternette N, Sahgal N, Lockstone H, et al. Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling. Cancer Cell 2011;20:524-537 https://doi.org/10.1016/j.ccr.2011.09.006
- Honda Y, Nakamura Y, Goto K, Terada H, Sentani K, Yasui W, et al. Tubulocystic renal cell carcinoma: a review of literature focused on radiological findings for differential diagnosis. Abdom Radiol (NY) 2018;43:1540-1545 https://doi.org/10.1007/s00261-018-1643-8
- Zhang J, Liu B, Song N, Hua L, Wang Z, Gu M, et al. Diagnosis and treatment of cystic renal cell carcinoma. World J Surg Oncol 2013;11:158
- Ching BC, Tan HS, Tan PH, Toh CK, Kanesvaran R, Ng QS, et al. Differential radiologic characteristics of renal tumours on multiphasic computed tomography. Singapore Med J 2017;58:262-266 https://doi.org/10.11622/smedj.2016081
- Fu W, Huang G, Moloo Z, Girgis S, Patel VH, Low G. Multimodality imaging characteristics of the common renal cell carcinoma subtypes: an analysis of 544 pathologically proven tumors. J Clin Imaging Sci 2016;6:50
- Moldovanu CG, Petresc B, Lebovici A, Tamas-Szora A, Suciu M, Crisan N, et al. Differentiation of clear cell renal cell carcinoma from other renal cell carcinoma subtypes and benign oncocytoma using quantitative MDCT enhancement parameters. Medicina (Kaunas) 2020;56:569
- Palmeiro MM, Niza JL, Loureiro AL, Conceicao e Silva JP. Unusual renal tumour: multilocular cystic renal cell carcinoma. BMJ Case Rep 2016;2016:bcr2016214386
- Campbell N, Rosenkrantz AB, Pedrosa I. MRI phenotype in renal cancer: is it clinically relevant? Top Magn Reson Imaging 2014;23:95-115 https://doi.org/10.1097/RMR.0000000000000019
- Weibl P, Hora M, Kollarik B, Kalusova K, Pitra T, Remzi M, et al. A practical guide and decision-making protocol for the management of complex renal cystic masses. Arab J Urol 2017;15:115-122 https://doi.org/10.1016/j.aju.2017.02.001
- Woo S, Kim SY, Lee MS, Moon KC, Kim SH, Cho JY, et al. MDCT findings of renal cell carcinoma associated with Xp11.2 translocation and TFE3 gene fusion and papillary renal cell carcinoma. AJR Am J Roentgenol 2015;204:542-549 https://doi.org/10.2214/AJR.14.12950
- Liang W, Xu S. Xp11.2 translocation renal cell carcinoma with egg-shell calcification mimicking a benign renal tumour: a case report. Oncol Lett 2015;10:3191-3194 https://doi.org/10.3892/ol.2015.3718